Concepedia

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre, Christine Lacabaratz, Sophie Grande, Neil Goldstein, Cynthia Robinson, Auguste Gaddah, Viki Bockstal, Aurélie Wiedemann,

The Lancet Infectious Diseases · 2020 · 170 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

Ana María Henao-Restrepo, Anton Camacho, Ira M. Longini et al. · The Lancet · 2016 · 1.1K citations · Full text

, , +17

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

Jason A. Regules, John H. Beigel, Kristopher Paolino et al. · New England Journal of Medicine · 2015 · 395 citations · Full text

, , +11

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman et al. · New England Journal of Medicine · 2015 · 356 citations · Full text

, , +14

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

Daphne A. Stanley, Anna N. Honko, Clement Asiedu et al. · Nature Medicine · 2014 · 352 citations

, , +16

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Iain Milligan, Malick M. Gibani, Richard P. Sewell et al. · JAMA · 2016 · 330 citations

, , +17